The novel treatment of the medication represents a major advance in the handling of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatide-peptide919316.dbblog.net/15424661/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment